Kanter GP - Search Results

1

Insurance and racial disparities in prior authorization in gynecologic oncology.

Smith AJB, Mulugeta-Gordon L, Pena D, Kanter GP, Bekelman JE, Haggerty A, Ko EM. Smith AJB, et al. Among authors: kanter gp. Gynecol Oncol Rep. 2023 Mar 11;46:101159. doi: 10.1016/j.gore.2023.101159. eCollection 2023 Apr. Gynecol Oncol Rep. 2023. PMID: 36942280 Free PMC article.

2

Growth Of Public Coverage Among Working Families In The Private Sector.

Strane D, Kanter GP, Matone M, Glaser A, Rubin DM. Strane D, et al. Among authors: kanter gp. Health Aff (Millwood). 2019 Jul;38(7):1132-1139. doi: 10.1377/hlthaff.2018.05286. Health Aff (Millwood). 2019. PMID: 31260364

3

Access to pharmacies and pharmacy services in New York City, Los Angeles, Chicago, and Houston, 2015-2020.

Guadamuz JS, Alexander GC, Zenk SN, Kanter GP, Wilder JR, Qato DM. Guadamuz JS, et al. Among authors: kanter gp. J Am Pharm Assoc (2003). 2021 Nov-Dec;61(6):e32-e41. doi: 10.1016/j.japh.2021.07.009. Epub 2021 Jul 19. J Am Pharm Assoc (2003). 2021. PMID: 34366287

4

An increase in multi-site practices: The shifting paradigm for gynecologic cancer care delivery.

Hicks-Courant K, Kanter GP, Giuntoli RL 2nd, Schapira MM, Bekelman JE, Latif NA, Haggerty AF, Morgan MA, Burger R, Ko EM. Hicks-Courant K, et al. Among authors: kanter gp. Gynecol Oncol. 2021 Jan;160(1):3-9. doi: 10.1016/j.ygyno.2020.10.030. Epub 2020 Nov 24. Gynecol Oncol. 2021. PMID: 33243442

5

Association of gynecologic oncology versus medical oncology specialty with survival, utilization, and spending for treatment of gynecologic cancers.

Ko EM, Bekelman JE, Hicks-Courant K, Brensinger CM, Kanter GP. Ko EM, et al. Among authors: kanter gp. Gynecol Oncol. 2022 Feb;164(2):295-303. doi: 10.1016/j.ygyno.2021.12.001. Epub 2021 Dec 20. Gynecol Oncol. 2022. PMID: 34949437

6

Intensity of end-of-life care for gynecologic cancer patients by primary oncologist specialty.

Hicks-Courant K, Kanter GP, Schapira MM, Brensinger CM, Liu Q, Ko EM. Hicks-Courant K, et al. Among authors: kanter gp. Int J Gynecol Cancer. 2022 Jun 6;32(6):695-703. doi: 10.1136/ijgc-2021-003285. Int J Gynecol Cancer. 2022. PMID: 35379689

7

Trends in Medically Integrated Dispensing Among Oncology Practices.

Kanter GP, Parikh RB, Fisch MJ, Debono D, Bekelman J, Xu Y, Schauder S, Sylwestrzak G, Barron JJ, Cobb R, Qato DM, Jacobson M. Kanter GP, et al. JCO Oncol Pract. 2022 Oct;18(10):e1672-e1682. doi: 10.1200/OP.22.00136. Epub 2022 Jul 13. JCO Oncol Pract. 2022. PMID: 35830621 Free PMC article.

8

Prior authorization in gynecologic oncology: An analysis of clinical impact.

Smith AJB, Mulugeta-Gordon L, Pena D, Kanter GP, Bekelman JE, Haggerty AE, Ko EM. Smith AJB, et al. Among authors: kanter gp. Gynecol Oncol. 2022 Dec;167(3):519-522. doi: 10.1016/j.ygyno.2022.10.002. Epub 2022 Oct 14. Gynecol Oncol. 2022. PMID: 36244827

9

Association between oral targeted cancer drug net health benefit, uptake, and spending.

Lau-Min KS, Wu Y, Rochester S, Bekelman JE, Kanter GP, Getz KD. Lau-Min KS, et al. Among authors: kanter gp. J Natl Cancer Inst. 2024 May 15:djae110. doi: 10.1093/jnci/djae110. Online ahead of print. J Natl Cancer Inst. 2024. PMID: 38745430

10

Cancer Treatment Before and After Physician-Pharmacy Integration.

Kanter GP, Ozluk P, Chi W, Fisch MJ, Debono D, Parikh RB, Jacobson M, Bekelman JE, DeVries A. Kanter GP, et al. JAMA Netw Open. 2024 May 1;7(5):e2412998. doi: 10.1001/jamanetworkopen.2024.12998. JAMA Netw Open. 2024. PMID: 38780938 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

41 results

Search Page